NO20074100L - Mikroimplantater for okulaer administrering - Google Patents

Mikroimplantater for okulaer administrering

Info

Publication number
NO20074100L
NO20074100L NO20074100A NO20074100A NO20074100L NO 20074100 L NO20074100 L NO 20074100L NO 20074100 A NO20074100 A NO 20074100A NO 20074100 A NO20074100 A NO 20074100A NO 20074100 L NO20074100 L NO 20074100L
Authority
NO
Norway
Prior art keywords
microplants
implants
ocular administration
methods
microns
Prior art date
Application number
NO20074100A
Other languages
English (en)
Other versions
NO339496B1 (no
Inventor
Thierry Nivaggioli
David A Weber
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of NO20074100L publication Critical patent/NO20074100L/no
Publication of NO339496B1 publication Critical patent/NO339496B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Radiology & Medical Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Det beskrives implantater og mikroimplantater som omfatter homogene blandinger av et virkestoff og en bionedbrytbar polymerer, som inkluderer mikroimplantater som har diametere på 483 ?m eller mindre og som kan avleveres til øyet ved bruk av selvforseglende metoder. Videre beskrives fremgangsmåter for fremstilling av implantatene og mikroimplantatene som fører til partier av høyt ensartede implantater og mikroimplantater innenfor meget snevre toleranseområder.
NO20074100A 2005-03-01 2007-08-08 Mikroimplantater for okulær administrering NO339496B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/070,158 US20060204548A1 (en) 2005-03-01 2005-03-01 Microimplants for ocular administration
PCT/US2006/006279 WO2006093758A1 (en) 2005-03-01 2006-02-22 Microimplants for ocular administration

Publications (2)

Publication Number Publication Date
NO20074100L true NO20074100L (no) 2007-11-23
NO339496B1 NO339496B1 (no) 2016-12-19

Family

ID=36579748

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074100A NO339496B1 (no) 2005-03-01 2007-08-08 Mikroimplantater for okulær administrering

Country Status (17)

Country Link
US (1) US20060204548A1 (no)
EP (2) EP1863420B1 (no)
JP (2) JP2008531687A (no)
KR (1) KR101271362B1 (no)
CN (1) CN101188989B (no)
AU (1) AU2006218931B2 (no)
BR (1) BRPI0607483A2 (no)
CA (1) CA2598512C (no)
ES (1) ES2678401T3 (no)
IL (1) IL185250A0 (no)
MX (1) MX2007010305A (no)
NO (1) NO339496B1 (no)
NZ (2) NZ588831A (no)
RU (1) RU2357709C1 (no)
TR (1) TR201810174T4 (no)
WO (1) WO2006093758A1 (no)
ZA (1) ZA200706622B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
AU2002236495B2 (en) 2000-11-29 2006-05-11 Allergan, Inc. Intraocular implants for preventing transplant rejection in the eye
US20050048099A1 (en) 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
US20050244469A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
EP2594259A1 (en) 2004-08-04 2013-05-22 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
US20060275230A1 (en) 2004-12-10 2006-12-07 Frank Kochinke Compositions and methods for treating conditions of the nail unit
CN101115475A (zh) * 2004-12-10 2008-01-30 塔利马治疗公司 用于治疗指甲单位病症的组合物和方法
US20070178138A1 (en) * 2006-02-01 2007-08-02 Allergan, Inc. Biodegradable non-opthalmic implants and related methods
JP5694664B2 (ja) * 2006-09-29 2015-04-01 サーモディクス，インコーポレイティド 生分解性眼用インプラント及び眼の病気を治療する方法
US8435544B2 (en) 2007-10-08 2013-05-07 Lux Biosciences, Inc. Ophthalmic compositions comprising calcineurin inhibitors or mTOR inhibitors
CA2709712C (en) 2007-12-20 2016-05-10 Surmodics Pharmaceuticals, Inc. Process for preparing microparticles having a low residual solvent volume
USRE48948E1 (en) 2008-04-18 2022-03-01 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable polymer
US8557273B2 (en) * 2008-04-18 2013-10-15 Medtronic, Inc. Medical devices and methods including polymers having biologically active agents therein
US20100239632A1 (en) 2009-03-23 2010-09-23 Warsaw Orthopedic, Inc. Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
AU2010256558B2 (en) 2009-06-03 2013-10-03 Forsight Labs, Llc Anterior segment drug delivery
WO2010144194A1 (en) 2009-06-09 2010-12-16 Lux Biosciences, Inc. Topical drug delivery systems for ophthalmic use
US8529492B2 (en) 2009-12-23 2013-09-10 Trascend Medical, Inc. Drug delivery devices and methods
US8349005B2 (en) 2011-01-03 2013-01-08 Masatoshi Murata Method for burying implant to choroid
RU2740680C2 (ru) * 2011-09-14 2021-01-19 Форсайт Вижн5, Инк. Глазное вкладочное устройство и способы
RU2494775C1 (ru) * 2012-06-21 2013-10-10 Федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения и социального развития Российской Федерации Способ лечения люэтической оптической нейропатии
KR101964582B1 (ko) * 2012-06-29 2019-04-03 존슨 앤드 존슨 비젼 케어, 인코포레이티드 눈의 갈바닉 치유를 위한 안과용 기구
EP2911623B1 (en) 2012-10-26 2019-08-14 Forsight Vision5, Inc. Ophthalmic system for sustained release of drug to eye
EP2968886A1 (en) 2013-03-14 2016-01-20 Hallux, Inc. Method of treating infections, diseases or disorders of nail unit
RU2557925C1 (ru) * 2014-03-17 2015-07-27 Новиков Сергей Викторович Биодеградируемый многослойный имплант для введения лекарственных веществ в витреальную полость глаза
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
TWI799366B (zh) 2015-09-15 2023-04-21 美商建南德克公司 胱胺酸結骨架平臺
JP6959912B2 (ja) 2015-09-23 2021-11-05 ジェネンテック， インコーポレイテッド 抗ｖｅｇｆ抗体の最適化変異体
JP6712003B2 (ja) 2016-10-28 2020-06-17 スパインセラＳｐｉｎｅｔｈｅｒａ 医薬組成物及びその使用
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis
CN107595765A (zh) * 2017-09-22 2018-01-19 沈阳兴齐眼药股份有限公司 一种眼用缓释药物递送系统及其制备方法
US20230248689A1 (en) * 2020-06-26 2023-08-10 Purdue Research Foundation Pharmaceutical formulations of griseofulvin for long-term ocular delivery
AU2022406897A1 (en) * 2021-12-06 2024-07-04 Ocular Therapeutix, Inc. Extruded ocular inserts or implants and methods thereof
US11883561B1 (en) * 2022-10-21 2024-01-30 Reselute, Inc. Drug eluting implants and methods for producing the same

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144317A (en) * 1975-05-30 1979-03-13 Alza Corporation Device consisting of copolymer having acetoxy groups for delivering drugs
US4346709A (en) * 1980-11-10 1982-08-31 Alza Corporation Drug delivery devices comprising erodible polymer and erosion rate modifier
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
JPS58126435U (ja) * 1982-02-19 1983-08-27 オリンパス光学工業株式会社 Ｔｔｌオ−トストロボ用絞り制御回路
US4668506A (en) * 1985-08-16 1987-05-26 Bausch & Lomb Incorporated Sustained-release formulation containing and amino acid polymer
US4959217A (en) * 1986-05-22 1990-09-25 Syntex (U.S.A.) Inc. Delayed/sustained release of macromolecules
US4997652A (en) * 1987-12-22 1991-03-05 Visionex Biodegradable ocular implants
US4853224A (en) * 1987-12-22 1989-08-01 Visionex Biodegradable ocular implants
US5164188A (en) * 1989-11-22 1992-11-17 Visionex, Inc. Biodegradable ocular implants
US5178635A (en) * 1992-05-04 1993-01-12 Allergan, Inc. Method for determining amount of medication in an implantable device
US5443505A (en) * 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
US5466233A (en) * 1994-04-25 1995-11-14 Escalon Ophthalmics, Inc. Tack for intraocular drug delivery and method for inserting and removing same
US6855331B2 (en) * 1994-05-16 2005-02-15 The United States Of America As Represented By The Secretary Of The Army Sustained release hydrophobic bioactive PLGA microspheres
US6369116B1 (en) * 1995-06-02 2002-04-09 Oculex Pharmaceuticals, Inc. Composition and method for treating glaucoma
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
US20020111603A1 (en) * 1996-12-02 2002-08-15 Societe De Conseils De Recherches Et D'application Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process
RU2120254C1 (ru) * 1997-10-28 1998-10-20 Институт нефтехимического синтеза им.А.В.Топчиева РАН Имплантат для реконструктивно-восстановительной хирургии
US6331313B1 (en) * 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
US6726918B1 (en) * 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
AU2002236495B2 (en) * 2000-11-29 2006-05-11 Allergan, Inc. Intraocular implants for preventing transplant rejection in the eye
MXPA04006875A (es) * 2002-01-18 2004-12-06 Control Delivery Sys Inc Sistema de gel polimerico para suministro controlado de cofarmacos.
US6899717B2 (en) * 2002-09-18 2005-05-31 Allergan, Inc. Methods and apparatus for delivery of ocular implants
US20050048099A1 (en) * 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
US20040137059A1 (en) * 2003-01-09 2004-07-15 Thierry Nivaggioli Biodegradable ocular implant

Also Published As

Publication number Publication date
AU2006218931A1 (en) 2006-09-08
CA2598512A1 (en) 2006-09-08
EP1863420A1 (en) 2007-12-12
IL185250A0 (en) 2008-02-09
NO339496B1 (no) 2016-12-19
CA2598512C (en) 2018-08-14
JP2013067644A (ja) 2013-04-18
NZ588831A (en) 2012-05-25
ZA200706622B (en) 2008-09-25
RU2357709C1 (ru) 2009-06-10
CN101188989A (zh) 2008-05-28
RU2007132699A (ru) 2009-04-10
MX2007010305A (es) 2007-09-27
KR101271362B1 (ko) 2013-06-10
EP1863420B1 (en) 2018-04-18
NZ560397A (en) 2010-11-26
BRPI0607483A2 (pt) 2009-09-08
US20060204548A1 (en) 2006-09-14
KR20070116030A (ko) 2007-12-06
JP2008531687A (ja) 2008-08-14
CN101188989B (zh) 2010-06-23
TR201810174T4 (tr) 2018-08-27
ES2678401T3 (es) 2018-08-10
WO2006093758A1 (en) 2006-09-08
EP2364680A1 (en) 2011-09-14
AU2006218931B2 (en) 2011-07-14

Similar Documents

Publication Publication Date Title
BRPI0607483A2 (pt) microimplantes para administração ocular
EP4613773A3 (en) Irak degraders and uses thereof
EP4596041A3 (en) Farnesoid x receptor agonists and uses thereof
AU2018338608A1 (en) Methods, compositions, and implantable elements comprising active cells
EP4445954A3 (en) Cellular models of and therapies for ocular diseases
WO2011079279A3 (en) Nanoconjugates and nanoconjugate formulations
EP2636416A3 (en) Phase-separated block copolymer coatings for implantable medical devices
EP3050876A3 (en) Kinase modulators
EP4545070A3 (en) Particles comprising a therapeutic or diagnostic agent and suspensions and methods of use thereof
WO2006132647A3 (en) Antimicrobial copolymers and uses thereof
MA28334A1 (fr) Compositions pharmaceutiques antivirales
BRPI0506983A (pt) composições para terapia localizada dos olhos, compreendendo preferencialmente acetonida de triancinolona e ácido hialurÈnico
WO2006081172A3 (en) Compounds and compositions as protein kinase inhibitors
EP2397148A3 (en) Compositions and methods for the treatment of ophthalmic disease
WO2007030266A3 (en) Nitric oxide-releasing polymers derived from modified polyimines
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
ATE530142T1 (de) Chirurgische artikel zur behandlung von beckenerkrankungen
WO2018212792A3 (en) BIOPOLYMER COMPOSITIONS, SCAFFOLDING AND DEVICES
AU2002342136A1 (en) Microfibrillated articles comprising hydrophilic component
MX382580B (es) Formulaciones de liberación inmediata disuasivas de abuso que comprenden polisacáridos no celulósicos.
EP4338802A3 (en) Tyk2 inhibitors, uses, and methods for production thereof
WO2008109347A3 (en) Methods for ex vivo administration of drugs to grafts using polymeric nanoparticles
EP2532657A3 (en) Compounds and methods of use
MX2023003556A (es) Composiciones farmaceuticas.
WO2004039248A3 (en) Repairing or replacing tissues or organs